| Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. | |
| | |
MedLine Citation:
|
PMID: 9098260 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To evaluate the epidemiology, possible etiologic factors, complications encountered, and treatment administered to a group of patients with ocular involvement in the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum who were seen at two large tertiary referral centers over a 34-year period. METHODS: Hospital records from 1960 to 1994 at the Massachusetts General Hospital and Shriners Hospital for Crippled Children were reviewed for patients with erythema multiforme, Stevens-Johnson syndrome, or toxic epidermal necrolysis. Only patients fulfilling specific clinical diagnostic criteria and those who received a diagnosis by a dermatologist were included in the review. RESULTS: A total of 366 patients with erythema multiforme, Stevens-Johnson syndrome, or toxic epidermal necrolysis were identified. Drugs were the most commonly identified etiologic factor in all three conditions: sulfonamides were the most frequently identified agents. Eighty-nine patients (24%) had ocular manifestations at the time of their acute hospital stay. Ocular involvement was seen in 9% of patients with erythema multiforme, in 69% with Stevens-Johnson syndrome, and in 50% with toxic epidermal necrolysis. The ocular problems were more severe in patients with both Stevens-Johnson syndrome and toxic epidermal necrolysis. There was no significant difference between the number of patients who were treated with systemic steroids and those who were not (P = 0.42). CONCLUSIONS: The erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum remains an important cause of severe visual loss in a significant number of patients. Systemic steroids used during the acute phase of the disease appear to have no effect on the development of ocular manifestations. Studies on the acute immunopathogenic mechanisms occurring in these disease are warranted if more effective therapies are to be found. |
| | |
Authors:
|
W J Power; M Ghoraishi; J Merayo-Lloves; R A Neves; C S Foster |
Publication Detail:
|
Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Ophthalmology Volume: 102 ISSN: 0161-6420 ISO Abbreviation: Ophthalmology Publication Date: 1995 Nov |
Date Detail:
|
Created Date: 1997-05-09 Completed Date: 1997-05-09 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7802443 Medline TA: Ophthalmology Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1669-76 Citation Subset: IM |
Affiliation:
|
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston 02114, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Adult Anti-Bacterial Agents / administration & dosage, therapeutic use Epidermal Necrolysis, Toxic / complications* Erythema Multiforme / complications* Eye Diseases / drug therapy, epidemiology, etiology* Female Follow-Up Studies Glucocorticoids / administration & dosage, therapeutic use Humans Male Massachusetts / epidemiology Ophthalmic Solutions Retrospective Studies Stevens-Johnson Syndrome / complications* |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Bacterial Agents; 0/Glucocorticoids; 0/Ophthalmic Solutions |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Immunopathologic study of the conjunctiva in patients with behçet disease.
Next Document: Stevens-Johnson syndrome associated with methazolamide treatment reported in two Japanese-American w...